Under section 14(9) of the Dumping and Countervailing Duties Act 1988 (“the Act”), anti-dumping duties imposed on oral liquid paracetamol from the Republic of Ireland*, will cease to apply to those goods on 30 March 2010, unless at that date the goods are subject to review under section 14(8) of the Act.
Any interested party that might request that the Chief Executive of the Ministry of Economic Development initiate a review before the cessation date referred to above, should be aware that positive evidence justifying the need for a review must be provided to the chief executive.
If an application is received which provides positive evidence justifying the need for a review, the chief executive must undertake and complete a review investigation within 180 days of initiation, on whether the anti-dumping duties should continue to be applied.
Positive evidence justifying the need for a review would need to include reasons for believing that the expiration of anti-dumping duties would see the continuation or recurrence of dumping of oral liquid paracetamol from the Republic of Ireland, and for believing that such dumping would be likely to cause the continuation or recurrence of material injury to the New Zealand industry producing oral liquid paracetamol.
The reasons should be supported by evidence and not be based on mere allegations or assertions.
Further information is available from the Manager, Trade Rules, Remedies and Tariffs Group, Competition, Trade and Investment Branch, Ministry of Economic Development,
PO Box 1473, Wellington 6140, or on facsimile (04) 499 8508 or email
traderem@med.govt.nz
Signed at Wellington this 22nd day of September 2009.
ROBIN HILL, Acting Manager, Trade Rules, Remedies and Tariffs Group.
*Refer to “Final Determination of Dumping Investigation: Oral Liquid Paracetamol from the Republic of Ireland” published in the New Zealand Gazette, 7 April 2005, No. 62, page 1548.